Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...